Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 12

The role of oxidative DNA damage and GSTM1, GSTT1, and hOGG1 gene polymorphisms in coronary artery disease risk

Pages
931–939
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, GSTM1, GSTT1, and hOGG1 gene polymorphisms seemed to have no effect on individual susceptibility for disease progression

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Atherosclerotic coronary artery disease (CAD) appears to be a multifactorial process caused by the interaction of environmental risk factors with multiple predisposing genes.
📊
Key Findings & Data:Therefore, in this study we aimed to determine the role of oxidative DNA damage and some variations in glutathione S-transferase (GSTM1 and GSTT1) and DNA repair (hOGG1) genes in CAD risk.Methods: A case-control study was conducted on 59 individuals who had undergone coronary angiographic evaluation.
💡
Conclusion & Impact:However, GSTM1, GSTT1, and hOGG1 gene polymorphisms seemed to have no effect on individual susceptibility for disease progression
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Atherosclerotic coronary artery disease (CAD) appears to be a multifactorial process caused by the interaction of environmental risk factors with multiple predisposing genes. Therefore, in this study we aimed to determine the role of oxidative DNA damage and some variations in glutathione S-transferase (GSTM1 and GSTT1) and DNA repair (hOGG1) genes in CAD risk.Methods: A case-control study was conducted on 59 individuals who had undergone coronary angiographic evaluation. Of these, 29 were patients diagnosed with CAD (mean age =61.5±10.3) and 30 were controls examined for reasons other than suspected CAD and who had angiographically documented normal coronary arteries (mean age =60.4±11.6). Basal DNA damage as well as pyrimidine and purine base damage were evaluated in peripheral blood lymphocytes using the modified comet assay. Polymerase chain reaction-restriction length polymorphism (PCR-RFLP)-based assay was used for genotyping.Results: Basal DNA damage levels in patients [9.16 (3.26)] were significantly higher than those in controls [7.59 (3.23); p=0.017], and basal DNA and pyrimidine base damage levels were significantly correlated with disease severity based on Gensini scoring (r=0.352, p=0.006; r=0.318, p=0.014, respectively). However, no significant differences were observed in terms of oxidized DNA bases between patients and controls. The frequencies of studied genotypes (GSTM1, GSTT1, and hOGG1) were similar between groups.Conclusion: The results of this study pointed out the role of DNA damage in CAD and its severity. However, GSTM1, GSTT1, and hOGG1 gene polymorphisms seemed to have no effect on individual susceptibility for disease progression

🔖

Cite This Article

KADIOĞLU, E., TAÇOY, G., ÖZÇAĞLI, E., OKYAY, K., AKBOĞA, M. K., ÇENGEL, A., ŞARDAŞ, S. (2016). The role of oxidative DNA damage and GSTM1, GSTT1, and hOGG1 gene polymorphisms in coronary artery disease risk. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 12, 931–939. https://ajindex.com/articles/365467

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138: 419-20
  2. Hauser ER, Pericak-Vance MA. Genetic analysis for common complex disease. Am Heart J 2000; 140: 36-44
  3. Rajesh KG, Surekha RH, Mrudula SK, Prasad Y, Sanjib KS, Prathiba N. Oxidative and nitrosative stress in association with DNA damage in coronary heart disease. Singapore Med J 2011; 52: 283-8
  4. Demirbağ R, Yılmaz R, Koçyiğit A. Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat Res 2005; 570: 197-203
  5. Botto N, Rizza A, Colombo MG, Mazzone AM, Manfredi S, Masetti S, et al. Evidence for DNA damage in patients with coronary artery disease. Mutat Res 2001; 493: 23-30
  6. Botto N, Masetti S, Petrozzi L, Vassalle C, Manfredi S, Biagini A, et al. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis 2002; 13: 269-74
  7. Taşpınar M, Aydos S, Sakırağaoğu O, Düzen IV, Yalçınkaya A, Öztuna D, et al. Impact of genetic variations of the CYP1A1, GSTT1, and GSTM1 genes on the risk of coronary artery disease. DNA Cell Biol 2012; 31: 211-8
  8. Olshan AF, Li R, Pankow JS, Bray M, Tyroler HA, Chambless LE, et al. Risk of atherosclerosis: interaction of smoking and glutathione S-transferase genes. Epidemiology 2003; 14: 321-7
  9. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. GlutathioneS-transferase family of enzymes. Mutat Res 2001; 482: 21-6
  10. Kim SJ, Kim MG, Kim KS, Song JS, Yim SV, Chung JH. Impact of glutathione S-transferase M1 and T1 gene polymorphisms on the smoking-related coronary artery disease. J Korean Med Sci 2008; 23: 365-72
  11. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 1513-30
  12. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998; 16: 3219-25
  13. Collins AR, Duthie SJ, Dobson VL. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 1993; 14: 1733-5
  14. Güven M, Güven GS, Öz E, Özaydın A, Batar B, Ulutin T, et al. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels 2007; 22: 355-60
  15. Gensini GG. A more meaningful scoring system for determining the severity of coronary h